Ankit Mahadevia

(Dr. Ankit Mahadevia)

Currently holds a position at Spero Therapeutics Inc

Positions

Position Company Period
President, Chief Executive Officer, Director Spero Therapeutics Inc March 1, 2015 -
Ankit Mahadevia's trades of Spero Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-05 2025-02-05
S Sale
55,260 -7.4%
0.78
USD 43,103 		55,260 -7.4% 0.78 USD 43,103
2025-02-05 2025-02-05
S Sale
13,959 -1.8%
0.78
USD 10,888 		13,959 -1.8% 0.78 USD 10,888
2024-08-29 2024-08-27
S Sale
5,912 -0.8%
1.35
USD 7,981 		5,912 -0.8% 1.35 USD 7,981
2024-02-05 2024-02-02
S Sale
63,795 -7.9%
1.37
USD 87,399 		63,795 -7.9% 1.37 USD 87,399
2023-08-30 2023-08-28
S Sale
9,040 -1.1%
1.26
USD 11,390 		9,040 -1.1% 1.26 USD 11,390
2023-02-06 2023-02-03
S Sale
12,286 -1.5%
1.81
USD 22,238 		12,286 -1.5% 1.81 USD 22,238
2020-11-05 2020-11-04
PS Planned sale
7,370 -10.1%
14.43
USD 106,335 		7,370 -10.1% 14.43 USD 106,335
2020-11-05 2020-11-03
PS Planned sale
2,137 -3.1%
14.27
USD 30,490 		2,137 -3.1% 14.27 USD 30,490
2020-10-27 2020-10-23
PS Planned sale
20 -0.0%
14.25
USD 285 		20 -0.0% 14.25 USD 285
2020-10-15 2020-10-14
PS Planned sale
105 -0.2%
14.25
USD 1,496 		105 -0.2% 14.25 USD 1,496
2020-10-15 2020-10-13
PS Planned sale
14,367 -17.9%
14.28
USD 205,212 		14,367 -17.9% 14.28 USD 205,212
2020-09-10 2020-09-08
PS Planned sale
774 -1.2%
14.25
USD 11,030 		774 -1.2% 14.25 USD 11,030
2020-07-09 2020-07-09
PS Planned sale
2,293 -3.4%
14.31
USD 32,807 		2,293 -3.4% 14.31 USD 32,807
2020-07-09 2020-07-07
PS Planned sale
754 -1.1%
14.25
USD 10,745 		754 -1.1% 14.25 USD 10,745
// ... existing code ... // ... rest of the file ...